- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 313
Booksy slots in $70m
The Müller Medien-backed beauty services marketplace has collected $70m in a series C round that boosted its overall funding to more than $116m.
Jan 29, 2021Kate Farms' series B reaches $60m
Main Street Advisors has invested $9m in the plant-based formula provider through a round already backed by Kaiser Permanente Ventures.
Jan 29, 2021Raydiant raises $13m in series A
The Bloomberg Beta-backed signage software producer boosted its overal funding to $20m with a round co-led by existing investors 8VC and Atomic.
Jan 29, 2021Stripe supports Check’s $35m series B
Stripe helped the payroll software developer hit $44m in total funding, backing its series B round alongside Thrive Capital.
Jan 28, 2021Classiq clasps series A funding
Sumitomo vehicle In Venture has invested in the quantum computing software startup through a $10.5m round as it looks to expand its engineering team.
Jan 28, 2021Token collects $15m in series B
The open banking technology provider lured Opera Tech Ventures, SBI Investment and Sony Innovation Fund by IGV for a round that brought its total funding to about $47m.
Jan 28, 2021Starship shoots to $17m
Goodyear Ventures and TDK Ventures have invested in the autonomous delivery service’s latest round, which took its overall funding to $102m.
Jan 28, 2021PlayVox stocks up with $25m
Five Elms Capital supplied the cash for customer service software provider PlayVox, which was backed by EPM's corporate venturing arm in 2015.
Jan 28, 2021Corporates connect to Lynk in $24m round
MassMutual Ventures co-led the knowledge expertise service's latest round, which included Alibaba Entrepreneurs Fund and brought its overall funding to $30m.
Jan 28, 2021Deerfield sets Nuvalent in motion with $50m series A
Harvard-founded Nuvalent lured funding from Deerfield to debut with two assets devoted to overcoming kinase-driven resistance to non-small cell lung cancer.
Jan 28, 2021About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


